Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2025-12-31 @ 8:47 PM
Study NCT ID:
NCT01896869
Status:
COMPLETED
Last Update Posted:
2020-05-19
First Post:
2013-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-08
First Submit QC Date:
None
Study First Post Date:
2013-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-22
Results First Submit QC Date:
None
Results First Post Date:
2020-05-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-05
Last Update Post Date:
2020-05-19
Last Update Post Date Type:
ACTUAL